NCT04736420View on ClinicalTrials.gov

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

78,605

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Venous Thromboembolism
Interventions
DRUG

Rivaroxaban

Rivaroxaban dispensing claim is used as the exposure group

DRUG

Warfarin

Warfarin dispensing claim is used as the reference group

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04736420 - Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter